SAFETY
Clinical trials for SAFETY explained in plain language.
Never miss a new study
Get alerted when new SAFETY trials appear
Sign up with your email to follow new studies for SAFETY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Mpox vaccine trial for pregnant women launches in congo
⭐️ VACCINE ⭐️ OngoingThis study tests the safety and immune response of the MVA-BN mpox vaccine in 359 pregnant and postpartum women in the Democratic Republic of the Congo. Some women receive the vaccine during pregnancy, others right after giving birth, and a small group gets it as an emergency sho…
Matched conditions: SAFETY
Phase: PHASE3 • Sponsor: Jean-Pierre Van geertruyden • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 04:04 UTC
-
Lupus patients may get new hope from engineered immune cells
Disease control TerminatedThis early-stage study tests a treatment called RD06-04, which uses a patient's own immune cells modified to target and attack lupus-causing cells. It involves 12 adults with moderate to severe lupus who have not responded well to standard treatments. The main goal is to check sa…
Matched conditions: SAFETY
Phase: NA • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 26, 2026 03:56 UTC
-
Wrist artery study aims to improve heart procedure safety
Knowledge-focused OngoingThis study is a registry that will track 3600 adults who need heart artery exams or treatments. Researchers want to see how well and how safely doctors can use a small wrist artery (the distal radial artery) for these procedures. The goal is to gather information, not to test a n…
Matched conditions: SAFETY
Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated May 26, 2026 03:58 UTC
-
12,000 koreans monitored for vaccine side effects over 6 years
Knowledge-focused OngoingThis study is tracking the safety of the BNT162b2 COVID-19 vaccine (including the bivalent version) in 12,000 people in Korea who received the vaccine as part of routine care. Researchers are collecting information on side effects that happen within a week and up to 28 days after…
Matched conditions: SAFETY
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated May 01, 2026 15:58 UTC